Clik here to view.
Clik here to view.
Project Data Sphere, LLC任命Kald Abdallah博士为Project Data Sphere总监
北卡罗来纳州卡利 (美国商业资讯)–Project Data Sphere, LLC任命医学博士和哲学博士Kald Abdallah为Project Data Sphere总监，负责www.ProjectDataSphere.org数据共享平台的持续快速发展。该平台提供广泛的癌症研究数据库访问权限，促成前所未有的研究合作，以解决复杂的科学问题。 Project Data Sphere,...
View ArticleClik here to view.
2014 International Symposium on Human Identification (ISHI) Celebrates 25...
MADISON, Wis. Twenty-five years ago, forensics was a very different field. Blood types were widely used as screening tools and DNA fingerprinting was in its infancy. Today, DNA forensics is part of...
View ArticleClik here to view.
《临床肿瘤学杂志》发表口服REVLIMID联合标准R-CHOP治疗弥漫大B细胞淋巴瘤患者的临床研究结果，总缓解率达到98%，完全缓解率达到80%
新泽西州萨米特 (美国商业资讯) — Celgene Corporation (NASDAQ:CELG)今天宣布，一项评估REVLIMID®（来那度胺）联合利妥昔单抗、环磷酰胺、盐酸多柔比星、硫酸长春新碱和泼尼松(R-CHOP)用于初治弥漫大B细胞淋巴瘤 (DLBCL)的研究结果在《临床肿瘤学杂志》印刷版出版之前在线发表。 该研究为II期、开放、单组研究，研究者是梅奥诊所(Mayo...
View ArticleClik here to view.
Article 7
米ニュージャージー州サミット （ビジネスワイヤ） — セルジーン・コーポレーション（NASDAQ:CELG）は本日、未治療のびまん性大細胞型B細胞性リンパ腫（DLBCL）患者を対象とするレブラミド（レナリドミド）とリツキシマブ、シクロホスファミド、ドキソルビシン塩酸塩、ビンクリスチン硫酸塩、プレドニゾン（R-CHOP）の併用療法を評価する試験の結果が、印刷版に先駆けてJournal of...
View ArticleClik here to view.
Beigene Enrolls First Patient in Phase 1 Study of BGB-3111
BEIJING BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced that it has dosed the first patient in a Phase 1...
View ArticleClik here to view.
Brainlab: First Patient Treatment with Revolutionary New Radiosurgery...
MUNICH, Germany New Automatic Brain Metastases Planning* software by Brainlab has been clinically used to successfully deliver fast, efficient radiosurgery treatment to a patient with metastatic...
View ArticleClik here to view.
BeiGene Expands Management Team with Two Strategic Senior Positions
BEIJING BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced the additions of two senior members to the...
View ArticleClik here to view.
World Economic Forum Selects Labcyte as 2015 Technology Pioneer
SUNNYVALE, Calif. Labcyte Inc., the company revolutionizing life science research with the Echo® acoustic liquid handler, was recognized by the World Economic Forum for demonstrating the ability to...
View ArticleClik here to view.
Centaur公布首席财务官过渡计划
圣安东尼奥 (美国商业资讯)– Centaur Guernsey L.P. Inc. (Centaur)今天宣布，Centaur及其业务子公司Kinetic Concepts, Inc.、LifeCell Corporation和Systagenix Wound Management, Limited的执行副总裁兼首席财务官Robert...
View ArticleClik here to view.
STROKE Treatments are available in Thailand by Phyathai 2 International Hospital
BANGKOK A stroke is a medical emergency and can cause permanent neurological damage or death. Europeans have a high risk factor for stroke. Risk factors for stroke include old age, eating junk food,...
View ArticleClik here to view.
エリテックが急性骨髄性白血病における第IIb相試験で2回目の肯定的なDSMB評価結果を発表
仏リヨン 急性白血病および医療ニーズが満たされていないその他の腫瘍適応症を対象に革新的な「腫瘍飢餓化」治療薬の開発に当たっているフランスのバイオ製薬企業エリテック・ファーマ（Paris:ERYP）（Euronext Paris: FR0011471135 –...
View ArticleClik here to view.
ボストン・ストラテジクス: 富士フイルムの抗がん剤FF-10501の再発・難治性骨髄異形成症候群（MDS）対象の第一相臨床試験を開始
ボストン （ビジネスワイヤ） — 米国マサチューセッツ州ボストンに本社を置く臨床ステージの総合医薬品研究開発会社Boston Strategics Corporation（BSC）は、富士フイルムの子会社 FUJI FILM Pharmaceuticals U.S.A., Inc. (FPHU)...
View ArticleClik here to view.
Elekta: Enhanced collaboration with Toshiba strengthens Elekta’s position in...
TOKYO Regulatory News: In an agreement signed today in Tokyo, Elekta Japan will grant Toshiba Medical Systems Corporation (TMSC) wider distribution rights regarding linear accelerator (linac) sales....
View ArticleClik here to view.
Solution Designed Specifically for Med/Surg Floors Addresses Unmet Patient...
RYDALMERE, Australia Welch Allyn, a leading medical diagnostic device company that delivers pragmatic innovation at the point of care, today introduced the industry’s most comprehensive clinical...
View ArticleClik here to view.
Teleflex to Present for the First Time at the 32nd Annual World Congress of...
WAYNE, Pa. Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care, urology and surgery, will present for the first time at the 32nd Annual World Congress...
View ArticleClik here to view.
CartiHeal Granted Four Patents Covering Agili-C™ Cartilage Regeneration...
KFAR SABA, Israel CartiHeal (2009) Ltd., a privately held medical device company headquartered in Kfar Saba, Israel, announces the issuance of four patents — three in the U.S. and one in Japan — for...
View ArticleClik here to view.
China’s Food and Drug Administration has Cleared NovaBay’s NeutroPhase Skin...
EMERYVILLE, Calif. & SHANGHAI NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective...
View ArticleClik here to view.
BSD Medical Completes Sale of Fourth BSD-2000 Hyperthermia System to Taiwan...
SALT LAKE CITY BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that treat cancer and benign diseases using heat therapy, announced...
View ArticleClik here to view.
Navidea Enters Lymphoseek® Development and Commercialization Agreement for China
DUBLIN, Ohio Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) has entered an exclusive agreement with a wholly-owned subsidiary of Hainan Sinotau Pharmaceutical Co., Ltd., a pharmaceutical...
View Article